* Aurora Cannabis Inc ACB.TO, ACB.TO is expected to show a fall in quarterly revenue when it reports results on September 27.
* The Alberta-based company is expected to report a 22.0% decrease in revenue to C$56.282 million from C$72.11 million a year ago, according to the mean estimate from 11 analysts, based on Refinitiv data.
* Refinitiv’s mean analyst estimate for Aurora Cannabis Inc is for a loss of 27 cents per share. For the same quarter last year, the company reported a loss of C$2.70 per share.
* The current average analyst rating on the shares is “sell” and the breakdown of recommendations is no “strong buy” or “buy,” 6 “hold” and 6 “sell” or “strong sell.”
* The mean earnings estimate of analysts was unchanged in the last three months.
* Wall Street’s median 12-month price target for Aurora Cannabis Inc is C$8, about 2.6% above its last closing price of C$7.79.
* Previous quarterly performance (using preferred earnings measure in Canadian dollars).
QUARTER ENDING
STARMINE
SMARTESTIMATE®
REFINITIV IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2021
-0.22
-0.22
-0.82
Missed
-267
Dec. 31 2020
-0.24
-0.25
-0.36
Missed
-45.9
Sep. 30 2020
-0.41
-0.40
-0.56
Missed
-39.5
Jun. 30 2020
-0.64
-2.58
-2.70
Missed
-4.5
Mar. 31 2020
-0.80
-0.76
-1.32
Missed
-73.7
Dec. 31 2019
-0.85
-0.67
-1.08
Missed
-61.9
Sep. 30 2019
-0.52
-0.52
0.12
Beat
123.2
Jun. 30 2019
-0.66
-0.59
0.00
Beat
100
This summary was machine generated September 24 at 20:03 GMT. All figures in Canadian dollars unless otherwise stated.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
www.nasdaq.com